Koers TetraLogic Pharmaceuticals Corporation Other OTC
Aandelen
TLOG
US88165U1097
Biotechnologie & Medisch Onderzoek
Omzet 2014 | - | Omzet 2015 | - | Marktkapitalisatie | 42,07 mln. 39,2 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2014 | -36 mln. -33,54 mln. | Nettowinst (verlies) 2015 | -49 mln. -45,65 mln. | EV/omzet 2014 | - |
Nettoliquiditeiten 2014 | 22,32 mln. 20,79 mln. | Nettoschuld 2015 | 7,92 mln. 7,38 mln. | EV/omzet 2015 | - |
K/w-verhouding 2014 |
-2,96
x | K/w-verhouding 2015 |
-0,82
x | Werknemers | - |
Dividendrendement 2014 * |
-
| Dividendrendement 2015 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
President | - | - | |
Treasurer | 66 | 01-02-14 | |
Dick L. Sherman
SEC | Corporate Secretary | 76 | 01-11-12 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,42% | 122 mld. | |
+19,02% | 113 mld. | |
+2,85% | 22,66 mld. | |
-16,20% | 21,34 mld. | |
-39,57% | 16,92 mld. | |
-11,63% | 16,68 mld. | |
-16,13% | 16,61 mld. | |
+2,68% | 13,62 mld. | |
+21,16% | 11,04 mld. |